sunitinib zentiva 50 mg capsule rigide
helvepharm ag - sunitinibum - capsule rigide - sunitinibum 50 mg, cellulosum microcristallinum, mannitolum, carmellosum natricum conexum corresp. natrium max. 0.81 mg, povidonum k 30, magnesii stearas, kapselhülle: e 172 (nigrum), e 172 (rubrum), e 172 (flavum), e 171, gelatina, drucktinte: lacca, e 171, propylenglycolum, pro capsula. - farmaco - synthetika
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agenti antineoplastici - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
sunitinib teva
teva b.v. - sunitinib - sunitinib
sunitinib sandoz
sandoz s.p.a. - sunitinib - sunitinib
sunitinib eg
eg s.p.a. - sunitinib - sunitinib
sunitinib cipla
cipla europe nv - sunitinib - sunitinib
sunitinib egis
egis pharmaceuticals plc - sunitinib - sunitinib
sunitinib bluepharma indstria
bluepharma industria farmaceutica s.a. - sunitinib - sunitinib
sunitinib koanaa
koanaa healthcare gmbh - sunitinib - sunitinib
sunitinib piramal
piramal critical care italia s.p.a. - sunitinib - sunitinib